Please use this identifier to cite or link to this item: http://repository.i3l.ac.id/jspui/handle/123456789/816
Full metadata record
DC FieldValueLanguage
dc.contributor.authorParikesit, Arli Aditya-
dc.contributor.authorSurjawan, Iwan-
dc.date.accessioned2023-07-28T07:05:34Z-
dc.date.available2023-07-28T07:05:34Z-
dc.date.issued2021-12-23-
dc.identifier.urihttp://repository.i3l.ac.id/jspui/handle/123456789/816-
dc.descriptionThis is one of the ideation product of the Penelitian Dasar DIKTI Grant about SARS-CoV-2 Drug Design. Moreover, the modules have been deployed in a CSR project in Kupang, NTT. You can check this paper for the evidence: https://journal.unnes.ac.id/nju/index.php/jpii/article/view/21437 "en_US
dc.language.isoenen_US
dc.publisherDirektorat Jendral Kekayaan Intelektualen_US
dc.relation.ispartofseriesEC00202183318;000308624-
dc.titleStructural Bioinformatics Approach: Study Case in SARS-CoV-2 Inhibitoren_US
dc.typeOtheren_US
Appears in Collections:Pharmacy

Files in This Item:
File Description SizeFormat 
6. sertifikat_EC00202183318.pdfCertificate2.02 MBAdobe PDFView/Open
5. Structural Bioinformatics Module rev AAP.pdfModule3.63 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.